Longitudinal assessment of late gadolinium enhancement progression in non-ischemic left ventricular dysfunction
Late gadolinium enhancement (LGE) is a robust prognostic marker in non-ischemic cardiomyopathies, yet its longitudinal evolution and clinical implications remain incompletely defined. We aimed to quantify LGE progression over time and evaluate its determinants and prognostic value in dilated cardiomyopathy (DCM)...